Company news
Sensei Biotherapeutics, Inc. news in 2024
Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
November 26, 2024
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 13, 2024
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
October 28, 2024
Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference
September 3, 2024
Sensei Biotherapeutics to Present at Upcoming Conferences
September 3, 2024
Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 5, 2024
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
May 29, 2024
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 22, 2024
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 8, 2024
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
April 23, 2024
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
April 8, 2024
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
April 3, 2024
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
March 21, 2024
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
March 5, 2024
Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
February 27, 2024
Decks in 2024
- Investor Presentation (June 2024)
Investor deck · 50 slides · Jun 3, 2024
- Investor Presentation (January 2024)
Investor deck · 42 slides · Jan 4, 2024